Search

Type

Audience

Category

Issue

Last updated

Recall class

Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.

Displaying 1 - 4 of 4 items.

" " ZINBRYTA (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis
ZINBRYTA (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis Starting date: March 16, 2018…
AlertHealth professional risk communication | 2018-03-16
" " 0.9% Sodium Chloride Injection, 250 mL (2018-03-16)
0.9% Sodium Chloride Injection, 250 mL (2018-03-16) Starting date: March 16, 2018 Posting date: March 16, 2018 Type of communication: Drug Recall Subcategory: Drugs Hazard…
RecallHealth product recall | 2018-03-16
" " Health Canada to conduct review of a new potential safety risk of Fibristal (ulipristal acetate), a medication used to treat fibroids
Health Canada to conduct review of a new potential safety risk of Fibristal (ulipristal acetate), a medication used to treat fibroids…
AlertInformation update | 2018-03-15
" " Phenylbutazone powder (2018-03-02)
Phenylbutazone powder (2018-03-02) Starting date: March 2, 2018 Type of communication: Drug Recall Subcategory: Veterinary Drugs Hazard classification: Type III Source of…
RecallHealth product recall | 2018-03-02
Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.